If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Acquisition

18 Jul 2023 07:00

RNS Number : 2908G
Kingspan Group PLC
17 July 2023
 

 

Kingspan Group plc

 

Acquisition

 

Inside Information

 

17 July 2023

 

Kingspan Group plc ("Kingspan") announces the acquisition of a majority stake in Steico SE

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, is pleased to announce that it has entered into an agreement with Schramek GmbH ("Schramek") to acquire c.51% of the shares of Steico SE ("Steico"), with an option to acquire a further c.10% of shares in Steico in the future.

 

Steico is the world leader in natural insulation and wood-based building envelope products, based in Germany and listed on the unofficial markets of several German Stock Exchanges. It has a very well invested asset base, with four large production sites comprising 27 lines situated in Poland and France, including additional capacity nearing completion with up to EUR200m revenue headroom.

 

Steico had audited operating revenues of EUR445m in the 12 months to 31 December 2022 and EBITDA of EUR90m in the same period. As at June 2023, Steico guided 2023 revenues of c.EUR378m at an EBIT margin of 8% - 10% (FY22 14.6%). As at 31 December 2022, Steico had gross assets of EUR509m.

 

The initial consideration for the shares will be EUR35 per share, plus potential deferred consideration of up to a further EUR35 per share contingent on achievement of specified thresholds with a material uplift in profitability. The initial consideration of approximately EUR251.4m will be satisfied on completion, with 25% of the consideration potentially being exchanged for new shares in Kingspan (subject to Kingspan share price at completion). The consideration payable under the put and call option to acquire Schramek's remaining c. 10% in Steico is for a capped amount based on a multiple of future earnings.

The acquisition is expected to be earnings neutral initially, based on Kingspan consensus EPS for 2023 and Steico guidance for 2023.

 

In addition to Steico's existing ambitious growth plans we anticipate significant long term leverage via the Kingspan sales channels. The existing Steico executive management team will be retained in the business, and will continue to manage and develop the business. Upon closing, Kingspan will seek fair representation on Steico's administrative board.

 

The acquisition is conditional on regulatory clearance, and is expected to complete in early 2024. Following completion, Steico will continue to maintain its listings on the German Stock Exchanges.

 

 

Gene Murtagh, Kingspan Chief Executive Officer, commented:

 

"The acquisition of a majority stake in Steico represents an exciting next step in our strategy to provide the full spectrum of insulation products. Its suite of wood-based building envelope solutions broadens our ability to enable our customers to meet their sustainability and energy performance needs. Kingspan's global routes to market, paired with our drive to innovate and widen the applications of Steico's current technologies, are key to our plans to bring Steico bio-based solutions to the next level."

 

Udo Schramek, Steico Chief Executive Officer, stated:

 

"It has been a great honour to lead the team at Steico to become the pre-eminent global supplier of wood-based insulation. We are now entering the next phase of growth and are very enthusiastic about the collaboration opportunities Kingspan brings, in both the existing Steico range and across the Kingspan portfolio and geographies. I am excited about the future for Steico and about being invested in the future growth of both companies."

 

 

Kingspan will hold an investor call at 8.30am IST on Tuesday 18 July 2023 to discuss the acquisition.

 

Operator Assisted Dial-In: United Kingdom (Local): +44 20 4587 0498 United Kingdom (Toll-Free): +44 800 358 1035 Access Code: 022503

 

Further call details will be available shortly on the Investor Relations section of our website www.kingspangroup.com. A recording of this conference call will be made available. For further information about the conference call please contact: ir@kingspan.com or +353 (0)42 969 8000.

 

 

Lorcan Dowd

Company Secretary

+ 353 (0)42 9698000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAPXXFDXDEFA
Date   Source Headline
1st Jul 201511:02 amRNSTotal Voting Rights
26th Jun 20155:14 pmRNSDirectorate Change
17th Jun 20154:16 pmRNSHolding(s) in Company
15th Jun 20155:13 pmRNSDirector/PDMR Shareholding
2nd Jun 20159:45 amRNSTotal Voting Rights
28th May 20154:49 pmRNSHolding(s) in Company
21st May 20159:47 amRNSHolding(s) in Company
21st May 20157:00 amRNSAcquisition completion
20th May 20155:58 pmRNSHolding(s) in Company
20th May 20155:24 pmRNSHolding(s) in Company
20th May 20157:00 amRNSAcquisition update
12th May 20159:56 amRNSHolding(s) in Company
7th May 201510:36 amRNSDirectorate Change
7th May 201510:31 amRNSAGM Results
7th May 20157:00 amRNSInterim Management Statement
1st May 20157:00 amRNSTotal Voting Rights
22nd Apr 20154:18 pmRNSDirector/PDMR Shareholding
1st Apr 20159:54 amRNSTotal Voting Rights
25th Mar 20154:38 pmRNSHolding(s) in Company
24th Mar 201512:22 pmRNSAnnual Financial Report
23rd Mar 20153:05 pmRNSTransaction in Own Shares
23rd Mar 20152:51 pmRNSAcquisition Update
19th Mar 20151:52 pmRNSHolding(s) in Company
16th Mar 20155:04 pmRNSAcquisition
13th Mar 201510:20 amRNSHolding(s) in Company
10th Mar 20156:11 pmRNSHolding(s) in Company
5th Mar 201512:16 pmRNSDirector/PDMR Shareholding
3rd Mar 201511:47 amRNSHolding(s) in Company
2nd Mar 201510:34 amRNSTotal Voting Rights
2nd Mar 20157:00 amRNSMain Securities Market Notice
27th Feb 20153:12 pmRNSDirector/PDMR Shareholding
27th Feb 20153:12 pmRNSDirector/PDMR Shareholding
25th Feb 20154:27 pmRNSHolding(s) in Company
24th Feb 20155:18 pmRNSDirector/PDMR Shareholding
24th Feb 20155:08 pmRNSBlock Listing Application
24th Feb 20155:07 pmRNSDirector/PDMR Shareholding
24th Feb 20155:02 pmRNSDirector/PDMR Shareholding
23rd Feb 20157:00 amRNSFinal Results
10th Feb 201510:23 amRNSHolding(s) in Company
9th Feb 20159:36 amRNSHolding(s) in Company
30th Jan 201512:16 pmRNSHolding(s) in Company
27th Jan 20157:01 amRNSAcquisition
26th Jan 20157:00 amRNSStatement re. Press Comment
13th Jan 201512:32 pmRNSHolding(s) in Company
12th Jan 20153:00 pmRNSHolding(s) in Company
6th Jan 20155:31 pmRNSHolding(s) in Company
2nd Jan 20157:00 amRNSBlocklisting Interim Review
2nd Jan 20157:00 amRNSTotal Voting Rights
17th Dec 20144:58 pmRNSHolding(s) in Company
1st Dec 201411:08 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.